In a nutshell The present study compared survivors of prostate cancer (PC) to patients of similar sexes and ages that have not had prostate cancer (non-cancer controls) based on the effects of prior treatments and treatment options on sexual, urinary, bowel and hormone functions. The main finding was that PC survivors had poorer sexual and urinary...
Read MoreCurrent stage?-Stage III Posts on Medivizor
Radiation therapy for prostate cancer: how long do urinary-related side effects last?
In a nutshell The present study examined the duration of urinary-related side effects resulting from radiation therapy. Mild to severe urinary side effects were found to last up to 10 years post radiation therapy. Some background Prostate cancer is a slow growing form of cancer that is often managed by active surveillance or observation (delayed...
Read MoreNew drugs for advanced prostate cancer
The aim of this article was to describe some of the most interesting developments concerning new therapies for advanced prostate cancer. During the last years new experimental therapeutic agents for the treatment of advanced prostate cancer have been developed. These are based on the recent discoveries on prostate cell function, resistance to...
Read MoreA new potential drug (mTOR inhibitor) for the treatment of metastatic prostate cancer
mTOR – which stands for mammalian target of rapamycin – is a protein that regulates vital cell growth processes. mTOR receives external signals from growth factors, hormones, and proteins. It then gives the 'on' or 'off' signals for the cell to grow and divide, or nourish itself. If a cell's mTOR is not properly regulating...
Read MoreChemotherapy Treatments For Triple-Negative Breast Cancer
This paper reviews chemotherapy options for triple-negative breast cancers. Breast cancer cells express 3 main receptors that can be targeted with therapy: Estrogen receptors (ER), Progesterone receptors (PR) and HER2. Triple-negative breast cancers (TNBCs) do not express these 3 receptors and make up approximately 15% of breast cancers. Such tumors do...
Read MoreComparison between laparoscopic and open surgery for colon cancer
In a nutshell The present study compares two surgical techniques for the treatment of colon cancer: Open Colectomy (OC) and Laparoscopic Assisted Colectomy (LAC). They found that LAC may be preferred to OC for removal of colon cancer. Some background The first treatment of choice for colon cancer which is localized to the colonic...
Read MorePreserving Fertility during Cancer Treatment
In a nutshell This paper reviews available options for having children after cancer treatment. The main conclusion is that sperm, egg and embryo preservation techniques can help young women have children after breast cancer treatment. Alternative options, such as ovarian tissue preservation, are also being developed. Some background...
Read MoreExperimental drug – Enzalutamide – moderately increases survival in patients with advanced prostate cancer
In a nutshell This clinical trial evaluated the survival benefits of a drug named Enzalutamide (Xtandi) for patients with non-responsive (refractory) advanced prostate cancer previously treated with chemotherapy. Main findings: Enzalutamide prolonged survival by approximately 5 months and reduced the risk of death by 37%. Some background The...
Read MoreStandard Chemotherapy versus Capecitabine (Xeloda) in Older Women with Early-Stage Breast Cancer
In a nutshell This trial compared standard chemotherapy regimens and Capecitabine (Xeloda) in women over 65 years old. The main outcome was that standard chemotherapy worked better in this age group. Some background Capecitabine is generally used in breast cancer resistant to other chemotherapy. It is also the first approved treatment that can be...
Read More